Evidence map›Paper›PMID 30598369›Full record

ArticleJournal of diabetes and its complications2019

Depressive symptom dimensions and medication non-adherence in suboptimally controlled type 2 diabetes.

Claire J Hoogendoorn, Amit Shapira, Juan F Roy, Elizabeth A Walker, Hillel W Cohen, Jeffrey S Gonzalez

Registry-linked trialAbstract read
In one paragraph

Article in Journal of diabetes and its complications, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04097483 (The TELE-DD Project), which is not on this map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04097483 nacompletednot on this map

The TELE-DD Project: a Nurse-led Randomised Controlled Trial on Treatment Adherence in Patients With Type 2 Diabetes and Comorbid Depression

TypeinterventionalSponsorAlicia Monreal BartoloméRan2017 to 2020Enrolled428ConditionsDiabetes Mellitus, Type 2, DepressionArmsTelephone Intervention Group
3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 33 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Claire J HoogendoornFerkauf Graduate School of Psychology, Yeshiva University, Bronx, NY, USA. Electronic address: claire.hoogendoorn@yu.edu.
Amit ShapiraFerkauf Graduate School of Psychology, Yeshiva University, Bronx, NY, USA.
Juan F RoyFerkauf Graduate School of Psychology, Yeshiva University, Bronx, NY, USA.
Elizabeth A WalkerDepartment of Medicine (Endocrinology), Albert Einstein College of Medicine, Bronx, NY, USA.
Hillel W CohenDepartment of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY, USA.
Jeffrey S GonzalezFerkauf Graduate School of Psychology, Yeshiva University, Bronx, NY, USA; Department of Medicine (Endocrinology), Albert Einstein College of Medicine, Bronx, NY, USA; The Fleischer Institute for Diabetes and Metabolism, Albert Einstein College of Medicine, Bronx, NY, USA.
Albert Einstein College of Medicine · USYeshiva University · US

Funding

Stable Isotope and Metabolomics CoreP60DK020541 · NIDDK · YESHIVA UNIVERSITY · PI FLEISCHER, NORMAN S. · 1986 to 2014
$29.8M
Translational Research CoreP30DK020541 · NIDDK · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI STREAMSON C CHUA · 2015 to 2026
$27.7M
CTSA Administrative Supplement for Informatics Core: A novel AI/ML system to predict respiratory failure and ARDS in Covid-19 patientsUL1TR002556 · NCATS · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI KELLER, MARLA J, KIM, MIMI Y · 2018 to 2022
$26.7M
New York Regional Center for Diabetes Translation Research - Translational Intervention Methodology CoreP30DK111022 · NIDDK · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI JEFFREY GONZALEZ · 2016 to 2026
$7.8M
Emotional Distress in a Comparative Effectiveness Trial of Diabetes TreatmentsR01DK104845 · NIDDK · GEORGE WASHINGTON UNIVERSITY · PI CHERRINGTON, ANDREA L, GONZALEZ, JEFFREY S · 2015 to 2019
$3.4M
Improving Diabetes Medication, Adherence and OutcomesR18DK062038 · NIDDK · YESHIVA UNIVERSITY · PI WALKER, ELIZABETH A. · 2003 to 2007
$3.1M
Translating telephonic diabetes self-management support to primary care practiceR18DK098742 · NIDDK · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI GONZALEZ, JEFFREY S, WU, WINFRED YOUNG · 2013 to 2017
$2.6M
NCATS NIH HHS UL1 TR002556NIDDK NIH HHS P30 DK020541NIDDK NIH HHS P30 DK111022NIDDK NIH HHS P60 DK020541NIDDK NIH HHS R01 DK104845NIDDK NIH HHS R18 DK062038NIDDK NIH HHS R18 DK098742
6 · The paper itself

Abstract

aimsResearch suggests differential effects for somatic and cognitive-affective depressive symptoms in predicting health outcomes. This study evaluated differential relations with medication non-adherence among disadvantaged, and predominantly immigrant adults with sub-optimally controlled type 2 diabetes (T2D).

methodsHealth plan members taking oral diabetes medication and who had A1c ≥ 7.5% were recruited for a trial of telephonic self-management support. A subset (n = 376; age, M = 55.6 ± 7.2 years; A1c M = 9.1% ± 1.6) completed the Patient Health Questionnaire-8 (PHQ-8). Diabetes medication adherence was measured by self-report and claims-based records. Multivariable logistic regression modeled depressive symptoms and odds of non-adherence using pre-intervention data.

resultsA positive PHQ-8 screen (OR = 2.72 [95%CI: 1.56-4.73]) and each standard deviation increase in PHQ-8 score (OR = 1.40 [95%CI: 1.11-1.75]) were associated with non-adherence, with no independent effects for somatic versus cognitive-affective symptoms. Exploration of individual symptoms identified three significantly associated with non-adherence in covariate-adjusted models; after adjustment for likely presence of clinical depression, only fatigue was independently associated with non-adherence (OR = 1.71 [95%CI: 1.06-2.77]).

conclusionsFindings support depression symptom severity as a significant correlate of medication non-adherence among disadvantaged adults with T2D. Support was limited for differential associations for symptom dimensions, but findings suggest that fatigue may be associated with non-adherence independent of the likely presence of depression.

Indexed as

AdultAgedDepressionDiabetes Mellitus, Type 2EthnicityFatigueFemaleGlycated HemoglobinHumansMaleMiddle AgedOdds RatioPatient ComplianceSurveys and QuestionnairesTreatment OutcomeGlycated HemoglobinCognitive-affective symptomsDepressionMedication adherenceSomatic symptomsType 2 diabetes

Identifiers

PMID30598369
PMCPMC6662178
OpenAlexW2905342096

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.